EP3463436
Bóluefni í samsetningu með ónæmis-varðstöðvarhindra til notkunar við meðhöndlun á krabbameini
Status:
EP Einkaleyfi fallið úr gildiEP appl. date:
2.6.2017EP published:
20.9.2023EP application number:
17729078.0
EP translation filed:
18.12.2023Grant published:
15.1.2024EPO information:
European Patent Register
Max expiry date:
1.6.2037Expiry date:
1.6.2025
Title in English:
A VACCINE IN COMBINATION WITH AN IMMUNE CHECKPOINT INHIBITOR FOR USE IN TREATING CANCERLanguage of the patent:
English
Timeline
Today
2.6.2017EP application
20.9.2023EP Publication
18.12.2023Translation submitted
15.1.2024Registration published
1.6.2025Expires
Owner
Name:
Ultimovacs ASAAddress:
Ullernchausséen 64, 0379 Oslo, NO
Inventor
Name:
GAUDERNACK, GustavAddress:
1337 Sandvika, NO
Name:
TORNES, AudunAddress:
3021 Drammen, NO
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
16172760Date:
2.6.2016Country:
EP
Classification
Categories:
A61K 39/00, C07K 16/28
Annual fees
Number
Paid
Expires
Payer
Number: 8
Paid: 7.5.2024
Expires: 1.6.2025
Payer: Árnason Faktor ehf.